| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $103.88M | - | |
| Dir | 1.55M | $82.12M | - | |
| Dir | 1.19M | $62.87M | - | |
| CFO | 1.12M | $59.07M | - | |
| VP | 594.7K | $31.44M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2019 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 217,404 | $20.59 | $4,477,307.04 | -38.2% | |
| Jun 13, 2019 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 27,596 | $20.03 | $552,747.88 | -19.1% | |
| Jun 10, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 1,000 | $20.23 | $20,230.00 | -1.1% | |
| Jun 4, 2019 | Scangos George A77 | Director | Sell | 40,000 | $19.76 | $790,250.00 | -1.6% | |
| May 10, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 1,000 | $19.58 | $19,580.00 | -1.1% | |
| May 8, 2019 | Morrissey Michael | President And CEO | Sale+OE | 42,000 | $20.15 | $846,300.00 | -31.8% | |
| May 8, 2019 | Willsey Lance | Director | Sell | 50,000 | $20.36 | $1,018,000.00 | -12.0% | |
| May 3, 2019 | Senner Christopher J. | EVP And CFO | Sell | 36,261 | $20.70 | $750,602.70 | -24.4% | |
| May 2, 2019 | Scangos George A77 | Director | Sell | 40,000 | $19.84 | $793,750.00 | -1.6% | |
| Apr 24, 2019 | Morrissey Michael | President And CEO | Sale+OE | 40,000 | $20.75 | $830,000.00 | -30.8% |